Dianthus Therapeutics | MGTA - Debt


Dianthus Therapeutics reported $1.28M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Celltrion KRW 171.09B 2.05T Jun/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Moderna USD 734M 7M Sep/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organon & Co USD 8.83B 68M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 49.42M 1.98M Dec/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025